SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Toxic masculinity: “Penetration should not be the end of sex”, says Sainte Paluche Nov 21, 2022
- Senate approves sanctioning with jail the use of explosives in fishing after case of dynamited dolphin Nov 18, 2022
- This artificial intelligence is capable of doing 600 tasks at any time May 27, 2022
- Galaxy Chromebook laptop complained of low battery, Samsung is trying to fix it May 2, 2020
- Ultra air will be investigated for misleading advertising after offering air tickets at $10,000 May 27, 2022
- Twitter now lets you choose who can reply to a tweet after posting it Jul 14, 2021
- Despite threats from Vladimir Putin, the United Kingdom announced that it will supply rocket launchers to Ukraine Jun 6, 2022